Imaging Science in Dentistry

Korean Academy of Oral and Maxillofacial Radiology (대한영상치의학회)
권호 표지
DOI QR코드

DOI QR Code

Bisphosphonate related osteonecrosis of the jaws: report of two cases

  • Han, Jin-Woo (Department of Oral and Maxillofacial Radiology and Research Institute of Oral Science, College of Dentistry, Gangneung-Wonju National University)
  • Received : 2011.01.22
  • Accepted : 2011.04.08
  • Published : 2011.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Bisphosphonates are compounds used to treat osteoporosis and malignant bone metastasis. Despite the benefits related to the use of these medications, osteonecrosis of the jaws is a significant complication in a subset of patients receiving these drugs. This complication occurs either spontaneously or after a simple dento-alveolar surgery. Recently there were two patients who showed the features of bisphosphonate related osteonecrosis of the jaws (BRONJ) in Gangneung-Wonju National University Dental Hospital. The patients revealed the clinical and radiological features of classical osteomyelitis. This report presents two cases of BRONJ which were examined by plain radiography and computed tomography.

Keywords

References

  1. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102 : 433-41. https://doi.org/10.1016/j.tripleo.2006.06.004
  2. Kos M, Kuebler JF, Luczak K, Engelke W. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk. J Craniomaxillofac Surg 2010; 38 : 255-9. https://doi.org/10.1016/j.jcms.2009.06.005
  3. Magopoulos C, Karakinaris G, Telioudis Z, Vahtsevanos K, Dimitrakopoulos I, Antoniadis K, et al. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol 2007; 28 : 158-63. https://doi.org/10.1016/j.amjoto.2006.08.004
  4. Lehrer S, Montazem A, Ramanathan L, Pessin-Minsley M, Pfail J, Stock RG, et al. Normal serum bone markers in bisphosphonate- induced osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106 : 389-91. https://doi.org/10.1016/j.tripleo.2008.01.033
  5. Campisi G, Di Fede O, Musciotto A, Lo Casto A, Lo Muzio L, Fulfaro F, et al. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. Ann Oncol 2007; 18 Suppl 6 : vi168-72. https://doi.org/10.1093/annonc/mdm250
  6. Morag Y, Morag-Hezroni M, Jamadar DA, Ward BB, Jacobson JA, Zwetchkenbaum SR, et al. Bisphosphonate-related osteonecrosis of the jaw: a pictorial review. Radiographics 2009; 29 : 1971-84. https://doi.org/10.1148/rg.297095050
  7. Ruggiero SL. Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci 2011; 1218 : 38-46. https://doi.org/10.1111/j.1749-6632.2010.05768.x
  8. Ficarra G, Beninati F. Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects. Head Neck Pathol 2007; 1 : 132-40. https://doi.org/10.1007/s12105-007-0033-2
  9. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61 : 1115-7. https://doi.org/10.1016/S0278-2391(03)00720-1
  10. Ortega C, Montemurro F, Faggiuolo R, Vormola R, Nanni D, Goia F, et al. Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis. Acta Oncol 2007; 46 : 664-8. https://doi.org/10.1080/02841860601185917
  11. Conte-Neto N, Bastos AS, Spolidorio LC, Marcantonio RA, Marcantonio E Jr. Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports. Head Face Med 2011; 7 : 7. https://doi.org/10.1186/1746-160X-7-7
  12. Abughazaleh K, Kawar N. Osteonecrosis of the jaws: what the physician needs to know: practical considerations. Dis Mon 2011; 57 : 231-41. https://doi.org/10.1016/j.disamonth.2011.03.011

Cited by

  1. Bevacizumab-Associated Osteonecrosis of the Wrist and Knee in Three Pediatric Patients With Recurrent CNS Tumors vol.31, pp.2, 2011, https://doi.org/10.1200/jco.2012.43.6733
  2. Denosumab, a RANKL Inhibitor, Induced Osteonecrosis of the Jaw vol.3, pp.1, 2011, https://doi.org/10.12677/hjs.2013.31001
  3. Denosumab Related Osteonecrosis of Jaw: a Case Report vol.9, pp.4, 2018, https://doi.org/10.5037/jomr.2018.9405